North America Genetic Testing Services Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Service Type (Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, and Others), Disease (Cancer, Metabolic Diseases, Cardiovascular Diseases, and Other Diseases), and Service Provider (Hospital-Based Laboratories, Diagnostic Laboratories, and Others)

No. of Pages: 101    |    Report Code: TIPRE00009262    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Genetic Testing Services Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Genetic Testing Services Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Genetic Testing Services Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Prevalence of Genetic Diseases
5.2 Market Opportunities
  • 5.2.1 Untapped Emerging Markets in Developing Countries
5.3 Future Trends
  • 5.3.1 Increasing Awareness And Acceptance Of Personalized Medicine
5.4 Impact of Drivers and Restraints

6. North America Genetic Testing Services Market Regional Analysis

6.1 North America Genetic Testing Services Market Overview
6.2 North America Genetic Testing Services Market Revenue 2020-2030 (US$ Million)
6.3 North America Genetic Testing Services Market Forecast Analysis

7. North America Genetic Testing Services Market Analysis – by Service Type

7.1 Predictive Testing
  • 7.1.1 Overview
  • 7.1.2 Predictive Testing: North America Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Carrier Testing
  • 7.2.1 Overview
  • 7.2.2 Carrier Testing: North America Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Prenatal Testing
  • 7.3.1 Overview
  • 7.3.2 Prenatal Testing: North America Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Newborn Screening
  • 7.4.1 Overview
  • 7.4.2 Newborn Screening: North America Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Genetic Testing Services Market Analysis – by Disease

8.1 Cancer
  • 8.1.1 Overview
  • 8.1.2 Cancer: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Metabolic Diseases
  • 8.2.1 Overview
  • 8.2.2 Metabolic Diseases: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Cardiovascular Diseases
  • 8.3.1 Overview
  • 8.3.2 Cardiovascular Diseases: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Other Diseases
  • 8.4.1 Overview
  • 8.4.2 Other Diseases: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Genetic Testing Services Market Analysis – by Service Provider

9.1 Hospital-Based Laboratories
  • 9.1.1 Overview
  • 9.1.2 Other Diseases: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Diagnostic Laboratories
  • 9.2.1 Overview
  • 9.2.2 Other Diseases: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Genetic Testing Services Market – North America Analysis

10.1 North America
  • 10.1.1 North America Genetic Testing Services Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 North America Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 US: North America Genetic Testing Services Market Breakdown, by Service Type
    • 10.1.1.1.2 US: North America Genetic Testing Services Market Breakdown, by Disease
    • 10.1.1.1.3 US: North America Genetic Testing Services Market Breakdown, by Service Provider
  • 10.1.1.2 Canada: North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Canada: North America Genetic Testing Services Market Breakdown, by Service Type
    • 10.1.1.2.2 Canada: North America Genetic Testing Services Market Breakdown, by Disease
    • 10.1.1.2.3 Canada: North America Genetic Testing Services Market Breakdown, by Service Provider
  • 10.1.1.3 Mexico : North America Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Genetic Testing Services Market Breakdown, by Service Type
    • 10.1.1.3.2 Mexico : North America Genetic Testing Services Market Breakdown, by Disease
    • 10.1.1.3.3 Mexico : North America Genetic Testing Services Market Breakdown, by Service Provider

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Genetic Testing Services Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 23andMe Holding Co
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Ambry Genetics Corp
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Eurofins Scientific SE
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Exact Sciences Corp
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Illumina Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Laboratory Corp of America Holdings
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 NeoGenomics Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Quest Diagnostics Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Centogene AG
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. 23andMe Holding Co                                         
  2. Ambry Genetics Corp                                 
  3. Eurofins Scientific SE       
  4. Exact Sciences Corp       
  5. F. Hoffmann-La Roche Ltd                  
  6. Illumina Inc                                              
  7. Laboratory Corp of America Holdings          
  8. NeoGenomics Inc                               
  9. Quest Diagnostics Inc   
  10. Centogene AG